Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

9,779

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

November 30, 2008

Study Completion Date

June 30, 2009

Conditions
Breast Neoplasms
Interventions
DRUG

exemestane

On tablet of 25 mg per day during 5 years

DRUG

tamoxifen

Two tablets of tamoxifen 10 mg per day during 2.5 to 3 years followed by one tablet of exemestane 25 mg per day during 2 to 2.5 years for a total duration of 5 years of treatment

Trial Locations (59)

13006

Pfizer Investigational Site, Marseille

13009

Pfizer Investigational Site, Marseille

13012

Pfizer Investigational Site, Marseille

13285

Pfizer Investigational Site, Marseille

13616

Pfizer Investigational Site, Aix-en-Provence

21000

Pfizer Investigational Site, Dijon

22105

Pfizer Investigational Site, Saint-Brieuc

25200

Pfizer Investigational Site, Montbéliard

26026

Pfizer Investigational Site, Montélimar

27000

Pfizer Investigational Site, Évreux

29283

Pfizer Investigational Site, Brest

29609

Pfizer Investigational Site, Brest

30900

Pfizer Investigational Site, Nîmes

31000

Pfizer Investigational Site, Toulouse

31240

Pfizer Investigational Site, L'Union

31400

Pfizer Investigational Site, Toulouse

33000

Pfizer Investigational Site, Bordeaux

33076

Pfizer Investigational Site, Bordeaux

33600

Pfizer Investigational Site, Pessac

34059

Pfizer Investigational Site, Montpellier

35033

Pfizer Investigational Site, Rennes

41000

Pfizer Investigational Site, Blois

44202

Pfizer Investigational Site, Nantes

44600

Pfizer Investigational Site, Saint-Nazaire

44805

Pfizer Investigational Site, Saint-Herblain

51100

Pfizer Investigational Site, Reims

52000

Pfizer Investigational Site, Chaumont

54000

Pfizer Investigational Site, Nancy

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

56001

Pfizer Investigational Site, Vannes

57072

Pfizer Investigational Site, Metz

58000

Pfizer Investigational Site, Vannes

59000

Pfizer Investigational Site, Lille

59170

Pfizer Investigational Site, Croix

59240

Pfizer Investigational Site, Dunkirk

59500

Pfizer Investigational Site, Douai

60200

Pfizer Investigational Site, Compiègne

64100

Pfizer Investigational Site, Bayonne

67000

Pfizer Investigational Site, Strasbourg

69008

Pfizer Investigational Site, Lyon

71100

Pfizer Investigational Site, Chalon-sur-Saône

74011

Pfizer Investigational Site, Annecy

75248

Pfizer Investigational Site, Paris

76600

Pfizer Investigational Site, Le Havre

80000

Pfizer Investigational Site, Amiens

82017

Pfizer Investigational Site, Montauban

83007

Pfizer Investigational Site, Draguignan

83056

Pfizer Investigational Site, Toulon

83400

Pfizer Investigational Site, Hyres

84082

Pfizer Investigational Site, Avignon

91130

Pfizer Investigational Site, Ris-Orangis

91480

Pfizer Investigational Site, Quincy-sous-Sénart

92200

Pfizer Investigational Site, Neuilly

92210

Pfizer Investigational Site, Saint-Cloud

06805

Pfizer Investigational Site, Cagne Sur Mer

Unknown

Pfizer Investigational Site, Lorient

Pfizer Investigational Site, Mareuil-lès-Meaux

06250

Pfizer Investigational Site, Mougins

06050

Pfizer Investigational Site, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY